AAAAAA

   
Results: 1-9 |
Results: 9
The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration
Authors: Mosnier, LO Lisman, T van den Berg, HM Nieuwenhuis, HK Meijers, JCM Bouma, BN
Citation: Lo. Mosnier et al., The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration, THROMB HAEM, 86(4), 2001, pp. 1035-1039
The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis
Authors: Mosnier, LO Mejers, JCM Bouma, BN
Citation: Lo. Mosnier et al., The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis, THROMB HAEM, 86(4), 2001, pp. 1040-1046
Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation
Authors: Mosnier, LO Elisen, MGLM Bouma, BN Mejers, JCM
Citation: Lo. Mosnier et al., Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation, THROMB HAEM, 86(4), 2001, pp. 1057-1064
Regulation of fibrinolysis in plasma by TAFI and protein C is dependent onthe concentration of thrombomodulin
Authors: Mosnier, LO Meijers, JCM Bouma, BN
Citation: Lo. Mosnier et al., Regulation of fibrinolysis in plasma by TAFI and protein C is dependent onthe concentration of thrombomodulin, THROMB HAEM, 85(1), 2001, pp. 5-11
Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)
Authors: Bouma, BN Marx, PF Mosnier, LO Meijers, JCM
Citation: Bn. Bouma et al., Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U), THROMB RES, 101(5), 2001, pp. 329-354
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is notassociated with increased plasma fibrinolysis
Authors: Lisman, T Leebeek, FWG Mosnier, LO Bouma, BN Meijers, JCM Janssen, HLA Nieuwenhuis, HK De Groot, PG
Citation: T. Lisman et al., Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is notassociated with increased plasma fibrinolysis, GASTROENTY, 121(1), 2001, pp. 131-139
Early p53-positive foci as indicators of tumor risk in ultraviolet-exposedhairless mice: Kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity
Authors: Rebel, H Mosnier, LO Berg, RJW Westerman-de Vries, A van Steeg, H van Kranen, HJ de Gruijl, FR
Citation: H. Rebel et al., Early p53-positive foci as indicators of tumor risk in ultraviolet-exposedhairless mice: Kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity, CANCER RES, 61(3), 2001, pp. 977-983
Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia
Authors: Meijers, JCM Oudijk, EJD Mosnier, LO Bos, R Bouma, BN Nieuwenhuis, HK Fijnheer, R
Citation: Jcm. Meijers et al., Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia, BR J HAEM, 108(3), 2000, pp. 518-523
Factor XI dependent and independent activation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in plasma associated with clot formation
Authors: Bouma, BN Mosnier, LO Meijers, JCM Griffin, JH
Citation: Bn. Bouma et al., Factor XI dependent and independent activation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in plasma associated with clot formation, THROMB HAEM, 82(6), 1999, pp. 1703-1708
Risultati: 1-9 |